ClinVar Miner

Submissions for variant NM_001283009.2(RTEL1):c.1992T>C (p.Asp664=)

gnomAD frequency: 0.81476  dbSNP: rs6062302
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 12
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000454461 SCV000540225 benign not specified 2018-03-21 criteria provided, single submitter clinical testing This "variant" is the major allele. The T allele is also present at a high allel e frequency (25%) and would therefore also be benign. http://gnomad.broadinstitu te.org/variant/20-62320968-T-C
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000589402 SCV000699744 benign not provided 2017-07-10 criteria provided, single submitter clinical testing Variant summary: The c.2064T>C (p.Asp688=) in RTEL1 gene is a synonymous change that involves a non-conserved nucleotide. 5/5 programs in Alamut predict that this does not affect a normal splicing pattern, however no functional studies supporting these predictions were published at the time of evaluation. The variant is present in the control population dataset of ExAC at frequency of 0.749 89112/119034 chrs tested), including numerous homozygous occurrences. This frequency exceeds the estimated maximum allele frequency for a pathogenic allele in this gene (0.0011). In addition, the variant is cited as Benign/Polymorphism by a reputable database/clinical laboratory. Taking together, based on the prevalence of this variant in general population the variant was classified as Benign.
Labcorp Genetics (formerly Invitae), Labcorp RCV001519412 SCV001728278 benign Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 2024-02-01 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001543245 SCV001761772 benign Dyskeratosis congenita, autosomal recessive 5 2021-07-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001543246 SCV001761773 benign Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 2021-07-10 criteria provided, single submitter clinical testing
GeneDx RCV000589402 SCV001960539 benign not provided 2019-01-14 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 30462709)
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan RCV000454461 SCV004232948 benign not specified 2024-01-24 criteria provided, single submitter clinical testing This variant is classified as Benign based on local population frequency. This variant was detected in 89% of patients studied by a panel of primary immunodeficiencies. Number of patients: 85. Only high quality variants are reported.
Breakthrough Genomics, Breakthrough Genomics RCV000589402 SCV005314075 benign not provided criteria provided, single submitter not provided
Natera, Inc. RCV001272646 SCV001454885 benign Dyskeratosis congenita 2020-09-16 no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000454461 SCV001951776 benign not specified no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000454461 SCV001974924 benign not specified no assertion criteria provided clinical testing
GenomeConnect, ClinGen RCV000589402 SCV002074738 not provided not provided no assertion provided phenotyping only Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.